Navigation Links
U.S. Market for Orthopedic Biomaterials 2012
Date:7/16/2012

nd detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. This is an executive summary only, the full report is also available for purchase.

 

TABLE OF CONTENTS...I

LIST OF FIGURES...X

LIST OF CHARTS... XVI

EXECUTIVE SUMMARY... 1

1.1 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS . 1

1.2 ORTHOPEDIC BIOMATERIAL MARKET GROWTH RATES... 2

1.3 BONE GRAFT SUBSTITUTE USAGE PER INDICATION. 3

1.4 MACHINED BONE ALLOGRAFT MARKET.. 4

1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET . 5

1.6 RESORBABLE FIXATION DEVICE MARKET ... 6

1.7 TENDON GRAFT MARKET. 7

1.8 CARTILAGE REPAIR MARKET... 8

1.9 PLATELET AND BONE MARROW CONCENTRATION MARKET... 9

1.10 ORTHOPEDIC STEM CELL MARKET .. 10

1.11 LEADING COMPETITORS ... 11

RESEARCH METHODOLOGY... 12

2.1 RESEARCH SCOPE ... 12

2.2 IDATA'S 9-STEP METHODOLOGY ... 12

Step 1: Project Initiation & Team Selection .. 13

Step 2: Prepare Data Systems and Perform Secondary Research. 15

Step 3: Preparation for Interviews & Questionnaire Design 16

Step 4: Performing Primary Research... 17

Step 5: Research Analysis: Establishing Baseline Estimates 19

Step 6: Market Forecast and Analysis ... 20

Step 7: Identify Strategic Opportunities 22

Step 8: Final Review and Market Release . 23

Step 9: Customer Feedback and Market Monitoring. 24

 

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW. 25

3.1 INTRODUCTION ... 25

3.1.1 Growth Factors. 26

3.1.2 Bone Graft Substitutes .. 26

3.1.3 Machined Bone Allografts 27

3.1.4 Hyaluronic Acid Viscosupplementation 27

3.1.5 Resorbable Fixation Devices 28

3.1.6 Tendon Grafts ...
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
2. BioElectronics Corporation Announces Initiative for UK and German Markets
3. Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market
4. 2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment
5. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
6. Diplomat Specialty Pharmacy Promotes Dr. Atheer Kaddis to Sr. Vice President of Sales and Marketing
7. Kinase Inhibitors Market to Reach $11.6 Billion in US, $40.3 Billion Globally by 2016
8. United States Market for Psoriatic Arthritis Pharmacotherapy
9. Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
10. Analysis of the North American Radiology Image and Information Management Systems Market
11. Sports Medicine Implants Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... PARSIPPANY, N.J., July 7, 2011 Watson Pharmaceuticals, Inc. ... United States Court of Appeals for the Federal Circuit ... Southern District of Florida,s February 2011 decision that Watson,s ... Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed an Abbreviated New Drug Application ... (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. ... of Shire LLC,s Vyvanse®. Vyvanse® is a prescription ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit 2Watson Confirms Vyvanse® Patent Challenge 2
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Milan, Altarum Institute VP and Chairman of the Black ... Speaker at Mexico City Business Council on AIDS, ... of,Altarum Institute and a prominent leader and advocate on ... on AIDS conference,Thursday, August 7th in Mexico City. The ...
... the wrong strains during flu season, the FDA should ... other changes to the vaccine composition, according to a ... of the Institute for Operations Research and the Management ... Influenza Vaccine Composition" is by Laura J. Kornish of ...
... Patient Safety Technology, HONOLULU, Aug. 5 ... Queen,s Medical Center will equip 100 additional ... Vigilance Systems,(LifeBed), bringing the total number LifeBed,s ... transforms any bed into a LifeBed, which,invisibly ...
... ... - Adjusted Diluted EPS(1) ... Full-Year 2008 Earnings Estimate - - Conference Call Scheduled ... WST ) today announced results for the second quarter,of 2008. Reported diluted earnings per share of $0.82 ...
... MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the third quarter, ended,June 30, ... Highlights: - Grew revenue in Q3 2008 ... comparable electrophysiology (EP) revenue in Q3 ...
... Backlog Reaches $72 ... Million ... Recently-introduced Odyssey System Building Strong Market Momentum, ST. LOUIS, Aug. 5 ... 2008. Revenue for the recent second quarter increased 36% to $10.7,million compared with ...
Cached Medicine News:Health News:New decision model seeks to avert flu vaccine mismatch of 2007-2008 season 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:West Announces Second Quarter 2008 Results 2Health News:West Announces Second Quarter 2008 Results 3Health News:West Announces Second Quarter 2008 Results 4Health News:West Announces Second Quarter 2008 Results 5Health News:West Announces Second Quarter 2008 Results 6Health News:West Announces Second Quarter 2008 Results 7Health News:West Announces Second Quarter 2008 Results 8Health News:West Announces Second Quarter 2008 Results 9Health News:West Announces Second Quarter 2008 Results 10Health News:West Announces Second Quarter 2008 Results 11Health News:West Announces Second Quarter 2008 Results 12Health News:West Announces Second Quarter 2008 Results 13Health News:West Announces Second Quarter 2008 Results 14Health News:West Announces Second Quarter 2008 Results 15Health News:West Announces Second Quarter 2008 Results 16Health News:West Announces Second Quarter 2008 Results 17Health News:West Announces Second Quarter 2008 Results 18Health News:West Announces Second Quarter 2008 Results 19Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 12Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 13Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3
... from medium compression weight ... provides upper back compression ... the arms. Arm length ... Wonderfabric™ unraveling. Velcro® closing ...
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Provides gentle compression above and below implants...
Medicine Products: